Global Dermatitis Market Report 2022 – Market Forecast, Trends And Strategies
20 May, 2022
The global dermatitis market size is expected to grow from $5.92 billion in 2021 to $6.37 billion in 2022 at a compound annual growth rate (CAGR) of 7.6%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global dermatitis market is expected to reach $8.06 billion in 2026 at a CAGR of 6.1%.
What is the Global Dermatitis Market?
The dermatitis market consists of sales of dermatitis drugs such as corticosteroids, calcineurin inhibitors, PDE4 inhibitors which are used to cure inflammation of the outer layer of the body, characterized by itchy rashes on swollen and reddened skin. Some of the major dermatitis drugs include Triamcinolone, Clobetasol, Betamethasone, Hydrocortisone, Fluocinonide and Clobex.
Get a Sample of the global dermatitis market report
What drives the Global Dermatitis Market?
Growth in atopic dermatitis market is primarily driven by the increasing global prevalence of the disease. Prevalence of dermatitis in children is estimated to be around 15-20% while it is 1-3% in adults. The rising cases of food allergies are adding to the prevalence of dermatitis which ultimately leads to the increase in demand for the medicines to cure this disease. For example, according to the allergy asthma network 2020, approximately 31.6 million people in the United States have some form of atopic dermatitis. The prevalence of atopic dermatitis globally in children have 15-20 percent and in adults have 1 to 3 percent.
Get the full global dermatitis industry report herehttps://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report
Global Dermatitis Market Segments
The global dermatitis market is segmented:
By Drug Class: Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors
By Distribution Channel: Hospital, Retail Pharmacies, Drug Stores, Online or Mail Pharmacies
By Route of Application: Topical, Oral, Injectable
By Application: Cancer, Blood Disorders, Chronic Diseases, Infectious Diseases
By Geography: The regions covered in the dermatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Dermatitis Global Market Report 2022 provides market size and growth forecasts for the global dermatitis market, global dermatitis market share, dermatitis market segments and geographies, dermatitis market competitive landscape including leading competitors’ revenues, profiles and market shares. The dermatitis market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Dermatitis Industry Players include LEO Pharma A/S, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Bayer HealthCare, Encore Dermatology Inc., Meda Pharmaceuticals, Allergan Plc. (Republic of Ireland) and Bristol-Myers Squibb. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.